SEC Form 4 · accession 0001209191-16-134996
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Froesel Jr.
Officer — Executive VP, CFO & Treasurer
Period of report
Aug 1, 2016
Accepted (ET)
Aug 2, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Aug 1, 2016 | F | 9,892 | $26.42 | D | 82,371 | D |
Table II — derivative securities
No Table II lines on this filing.